Role of mTOR in podocyte function and diabetic nephropathy in humans and mice-Reference-Cited by-同舟云学术

Role of mTOR in podocyte function and diabetic nephropathy in humans and mice

Published:2011-06-01 Issue:6 Volume:121 Page:2197-2209
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Gödel Markus,Hartleben Björn,Herbach Nadja,Liu Shuya,Zschiedrich Stefan,Lu Shun,Debreczeni-Mór Andrea,Lindenmeyer Maja T.,Rastaldi Maria-Pia,Hartleben Götz,Wiech Thorsten,Fornoni Alessia,Nelson Robert G.,Kretzler Matthias,Wanke Rüdiger,Pavenstädt Hermann,Kerjaschki Dontscho,Cohen Clemens D.,Hall Michael N.,Rüegg Markus A.,Inoki Ken,Walz Gerd,Huber Tobias B.

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference58 articles.

1. TOR Signaling in Growth and Metabolism

2. mTOR and S6K1 Mediate Assembly of the Translation Preinitiation Complex through Dynamic Protein Interchange and Ordered Phosphorylation Events

3. The mTOR/PI3K and MAPK pathways converge on eIF4B to control its phosphorylation and activity

4. Drosophila S6 Kinase: A Regulator of Cell Size

Cited by 478 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The relation of mTOR with diabetic complications and insulin resistance in patients with type 2 diabetes mellitus;Diabetology & Metabolic Syndrome;2024-09-11

2. The pivotal role of glucose transporter 1 in diabetic kidney disease;Life Sciences;2024-09

3. Endogenous adenine is a potential driver of the cardiovascular-kidney-metabolic syndrome;2024-08-20

4. Autophagy alterations in obesity, type 2 diabetes, and metabolic dysfunction-associated steatotic liver disease: the evidence from human studies;Internal and Emergency Medicine;2024-07-06

5. Mitochondrial dysfunction and NLRP3 inflammasome: key players in kidney stone formation;BJU International;2024-07-05